Science first. Community-backed. Company-executed.
Early capital, delivery partners, and DeSci infrastructure: the people and platforms behind ARTAN Bio.
VitaDAO
VitaDAO helped form the early capital and collaboration base around ARTAN’s longevity research. Community-backed DeSci support sits alongside company execution: science first, then the operational rigor of modern genetic medicine.
Visit VitaDAO
BIO
BIO is a DeSci network focused on biotech company formation. It connects research communities with the infrastructure needed to turn platform science into operating companies.
Visit BIO
Molecule
Molecule provides on-chain research IP infrastructure, allowing research IP to be shared and structured while the company builds toward the clinic with traditional biotech execution.
Visit Molecule
Syenex
Syenex is the delivery partner for Artan-201, our program targeting hematopoietic stem cells, which are the blood-forming stem cells that seed the entire blood and immune system. The collaboration pairs targeted delivery with lentivirus expression of a codon suppressor in a preclinical program build.
Visit Syenex
spARK Labs by ARK Invest
ARTAN Bio builds at spARK Labs by ARK Invest, the innovation hub in St. Petersburg, Florida. The affiliation gives the team a home base for execution as the platform advances from discovery toward translational studies.
Visit spARK Labs by ARK Invest